TFC forms JV to boost DMSO output

By Nick Taylor

- Last updated on GMT

Related tags: Joint venture

Rising demand in China has led to Toray Fine Chemicals (TFC) establishing a joint venture to produce dimethylsulfoxide (DMSO), a reaction solvent in pharma production.

Japan-based TFC has partnered with Sinopac Asset Management to establish the operation, which will invest $21m (€14.9m) to construct production facilities with an output of 10,000 tons a year.

In addition Sinopac’s production facility for dimethyl sulfide (DMS), an intermediate ingredient of DMSO, will be used by the joint venture.

TFC claims it is already the world’s biggest producer of DMSO, and the only in Japan, with a combined output of 17,000 tons a year from its sites in Chiba and Tokai, both of which are in its home nation.

By boosting production levels the companies believe they can take a larger share of the market for DMSO, which was estimated to be 60,000 tons in 2008 and is rising because of increased demand from China.

The joint venture will give TFC a base in China, with operations situated in Cangzhou, and help it meet the nation’s rising demand that is driven by growth in the pharma and agrochemical sectors, as well as increased need for cleaning agents.

TFC’s competitors in the DMSO market include Arkema and Gaylord Chemical.

Pharma applications

DMSO has an array of applications in the pharma industry and is widely used as a reaction agent in the synthesis of active pharmaceutical ingredients (API).

Proponents of DMSO claim it results in faster reactions than other solvents and is easily recyclable. It can be used in numerous reactions including esterification, alkylation and substitution.

In addition DMSO has a history of being used in drug delivery, high-throughput screening (HTS) and as a topical analgesic. The solvents ability to penetrate nails has led to it being combined with an antifungal to treat ailments.

Related news

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us


View more